Jeanne‐Marie Devaster

2.9k total citations
40 papers, 1.7k citations indexed

About

Jeanne‐Marie Devaster is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Jeanne‐Marie Devaster has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Infectious Diseases. Recurrent topics in Jeanne‐Marie Devaster's work include Influenza Virus Research Studies (18 papers), Respiratory viral infections research (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Jeanne‐Marie Devaster is often cited by papers focused on Influenza Virus Research Studies (18 papers), Respiratory viral infections research (16 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Jeanne‐Marie Devaster collaborates with scholars based in Belgium, United Kingdom and Czechia. Jeanne‐Marie Devaster's co-authors include Geert Leroux‐Roels, Isabel Leroux‐Roels, Thomas Vanwolleghem, Frédéric Clément, Mamadou Dramé, Astrid Borkowski, Tom Wilkinson, Mathieu Peeters, Paul Gillard and François Roman and has published in prestigious journals such as The Lancet, Gastroenterology and American Journal of Epidemiology.

In The Last Decade

Jeanne‐Marie Devaster

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeanne‐Marie Devaster Belgium 22 1.1k 372 361 328 171 40 1.7k
Raúl Ortíz de Lejarazu Spain 24 1.0k 0.9× 438 1.2× 431 1.2× 137 0.4× 158 0.9× 119 1.8k
Niranjan Bhat United States 22 1.1k 0.9× 773 2.1× 340 0.9× 187 0.6× 160 0.9× 55 2.2k
Paul Van Caeseele Canada 27 1.8k 1.6× 883 2.4× 155 0.4× 185 0.6× 192 1.1× 106 2.5k
Francisco Pozo Spain 33 2.6k 2.3× 1.2k 3.3× 234 0.6× 606 1.8× 237 1.4× 148 3.3k
Barbara D. Baxter United States 18 1.2k 1.1× 433 1.2× 189 0.5× 249 0.8× 58 0.3× 26 1.5k
Weigong Zhou United States 13 674 0.6× 635 1.7× 376 1.0× 147 0.4× 129 0.8× 18 1.7k
Annette Jepson United Kingdom 24 479 0.4× 310 0.8× 472 1.3× 263 0.8× 123 0.7× 38 1.7k
Haakon Sjursen Norway 23 952 0.8× 457 1.2× 492 1.4× 59 0.2× 149 0.9× 56 1.5k
Andrés Antón Spain 23 969 0.9× 721 1.9× 99 0.3× 203 0.6× 181 1.1× 114 1.6k
Kazunobu Ouchi Japan 27 1.8k 1.6× 247 0.7× 148 0.4× 307 0.9× 176 1.0× 146 2.7k

Countries citing papers authored by Jeanne‐Marie Devaster

Since Specialization
Citations

This map shows the geographic impact of Jeanne‐Marie Devaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanne‐Marie Devaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanne‐Marie Devaster more than expected).

Fields of papers citing papers by Jeanne‐Marie Devaster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanne‐Marie Devaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanne‐Marie Devaster. The network helps show where Jeanne‐Marie Devaster may publish in the future.

Co-authorship network of co-authors of Jeanne‐Marie Devaster

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanne‐Marie Devaster. A scholar is included among the top collaborators of Jeanne‐Marie Devaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanne‐Marie Devaster. Jeanne‐Marie Devaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vehreschild, Maria J. G. T., Dale N. Gerding, Oleg Krut, et al.. (2024). How to develop a controlled human infection model for Clostridioides difficile. Clinical Microbiology and Infection. 31(3). 373–379. 2 indexed citations
2.
Beran, Jiřı́, Thi Lien-Anh Nguyên, Olivier Gruselle, et al.. (2021). Respiratory syncytial virus acute respiratory infections in ≥ 65-year-old adults in long-term care facilities in the Czech Republic. Central European Journal of Public Health. 29(3). 167–176. 10 indexed citations
3.
Williams, Nicholas, Kristoffer Ostridge, Jeanne‐Marie Devaster, et al.. (2018). Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD. Respiratory Research. 19(1). 143–143. 24 indexed citations
4.
Ostridge, Kristoffer, Nicholas Williams, Viktoriya Kim, et al.. (2018). Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respiratory Research. 19(1). 31–31. 29 indexed citations
5.
Coombs, Ngaire, Karl J. Staples, Kristoffer Ostridge, et al.. (2017). Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort. European Respiratory Journal. 50(4). 1700853–1700853. 64 indexed citations
6.
Bekkat-Berkani, Rafik, Tom Wilkinson, Philippe Buchy, et al.. (2017). Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulmonary Medicine. 17(1). 79–79. 93 indexed citations
7.
Wilkinson, Tom, Emmanuel Aris, Simon Bourne, et al.. (2017). A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax. 72(10). 919–927. 139 indexed citations
8.
9.
Dewé, Walthère, et al.. (2015). A multi-criteria decision making approach to identify a vaccine formulation. Journal of Biopharmaceutical Statistics. 26(2). 352–364. 4 indexed citations
10.
Leroux‐Roels, Isabel, Jeanne‐Marie Devaster, Geert Leroux‐Roels, et al.. (2013). Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials. Vaccine. 33(4). 577–584. 52 indexed citations
11.
Pavía-Ruz, Noris, M Weber, YL Lau, et al.. (2013). A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age. Human Vaccines & Immunotherapeutics. 9(9). 1978–1988. 19 indexed citations
12.
Beran, Jiřı́, et al.. (2013). Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults. BMC Infectious Diseases. 13(1). 224–224. 52 indexed citations
13.
14.
Vesikari, Timo, Jiřı́ Beran, Serge Durviaux, et al.. (2011). Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for influenza infection in a vaccine efficacy trial. Journal of Clinical Virology. 53(1). 22–28. 3 indexed citations
15.
Launay, Odile, Corinne Desaint, Christine Durier, et al.. (2011). Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial. The Journal of Infectious Diseases. 204(1). 124–134. 43 indexed citations
16.
Baras, Benoı̂t, Jeanne‐Marie Devaster, Louis Fries, et al.. (2008). A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses. Influenza and Other Respiratory Viruses. 2(6). 251–260. 38 indexed citations
17.
Leroux‐Roels, Isabel, Astrid Borkowski, Thomas Vanwolleghem, et al.. (2007). Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. The Lancet. 370(9587). 580–589. 414 indexed citations
18.
Corvaglia, Luigi, Patrick Bontems, Jeanne‐Marie Devaster, et al.. (1999). Accuracy of serology and 13C-urea breath test for detection of Helicobacter pylori in children. The Pediatric Infectious Disease Journal. 18(11). 976–979. 40 indexed citations
19.
Moine, Olivier Le, et al.. (1994). Trypsin activity. Digestive Diseases and Sciences. 39(12). 2634–2638. 30 indexed citations
20.
Moine, Olivier Le, Jacques Devière, Jeanne‐Marie Devaster, et al.. (1994). Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. Journal of Hepatology. 20(6). 819–824. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raúl Ortíz de Lejarazu Breakdown of academic impact, for papers by Niranjan Bhat Breakdown of academic impact, for papers by Paul Van Caeseele Breakdown of academic impact, for papers by Francisco Pozo Breakdown of academic impact, for papers by Barbara D. Baxter Breakdown of academic impact, for papers by Weigong Zhou Breakdown of academic impact, for papers by Annette Jepson Breakdown of academic impact, for papers by Haakon Sjursen Breakdown of academic impact, for papers by Andrés Antón Breakdown of academic impact, for papers by Kazunobu Ouchi
Rankless by CCL
2026